CAFFX
Price
$44.04
Change
+$0.10 (+0.23%)
Updated
Jun 26 closing price
Net Assets
97.14B
CGFAX
Price
$85.81
Change
+$0.97 (+1.14%)
Updated
Jul 9 closing price
Net Assets
360.63B
Interact to see
Advertisement

CAFFX vs CGFAX

CAFFX vs CGFAX Comparison Chart in %
View a ticker or compare two or three
VS
CAFFX vs. CGFAX commentary
Jul 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAFFX is a StrongBuy and CGFAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CGFAX has more cash in the bank: 361B vs. CAFFX (97.1B). CGFAX pays higher dividends than CAFFX: CGFAX (0.23) vs CAFFX (0.00). CAFFX was incepted earlier than CGFAX: CAFFX (24 years) vs CGFAX (24 years). CAFFX (0.75) is less costly to investors than CGFAX (0.62). CAFFX is a more actively managed with annual turnover of: 36.00 vs. CGFAX (32.00). CAFFX (250) and CGFAX (250) have matching initial minimum investment requirements. CGFAX annual gain was more profitable for investors over the last year : 4.35 vs. CAFFX (-1.30). CGFAX return over 5 years is better than : 15.48 vs. CAFFX (3.62).
CAFFXCGFAXCAFFX / CGFAX
Total Expense Ratio0.750.62121%
Annual Report Gross Expense Ratio0.750.62121%
Fund Existence24 years24 years-
Gain YTD-4.1157.542-55%
Front LoadN/A4%-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets97.1B361B27%
Annual Yield % from dividends0.000.23-
Returns for 1 year-1.304.35-30%
Returns for 3 years25.1143.6158%
Returns for 5 years3.6215.4823%
Returns for 10 years74.20110.1267%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VLACX138.73N/A
N/A
Vanguard Large Cap Index Investor
BDBPX31.82N/A
N/A
iShares Russell 2000 Small-Cap Idx Inv P
MDDAX9.43N/A
N/A
MassMutual Diversified Value A
GTMRX19.22N/A
N/A
Goldman Sachs Small/Mid Cap Growth R
MCYAX16.47-0.01
-0.06%
NYLI Candriam Emerging Markets Eq Cl A